Key facts
- This page summarizes Daniel MacLachlan's Form 4 filing for Red Violet, Inc. (RDVT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jul 2021, 17:36.
Daniel MacLachlan - 12 Jul 2021 Form 4 Insider Report for Red Violet, Inc. (RDVT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RDVT
- Reported as of
- 12 Jul 2021
- Net transaction value
- -$785,626
- SEC form
- 4
- Accepted by SEC
- 14 Jul 2021, 17:36:03 UTC
- Next SEC filing
- 27 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel MacLachlan
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daniel MacLachlan filed Form 4 for Red Violet, Inc. (RDVT) on 14 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$785,626.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RDVT
transaction
Common Stock
Award
- Transaction value
- Shares
- +91,666
- Change %
- +46%
- Price
- Shares after
- 290,926
- Date
- 12 Jul 2021
- Ownership
- Direct
- Footnotes
- F1, F2
RDVT
transaction
Common Stock
Tax liability
- Transaction value
- $785,626
- Shares
- -36,071
- Change %
- -12%
- Price
- $21.78
- Shares after
- 254,855
- Date
- 12 Jul 2021
- Ownership
- Direct
- Footnotes
- F2, F3
RDVT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 466
- Date
- 12 Jul 2021
- Ownership
- Held in IRA
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the final vesting of 91,666 restricted stock units (RSUs) of the performance grant originally approved by the Company's Compensation Committee on September 5, 2018.
Footnote F2
Includes 30,000 RSUs originally granted on November 20, 2020, convertible into common stock of the issuer on a one-for-one basis, which vest in three equal installments on each of November 1, 2021, November 1, 2022, and November 1, 2023, subject to accelerated vested under certain conditions.
Footnote F3
Represents the disposition to issuer for tax obligations upon the vesting of RSUs.